Endpoints in clinical trials on transfusion requirements: the need for a structured approach

Abstract

TransfusionVolume 45, Issue s1 p. 9S-13S Endpoints in clinical trials on transfusion requirements: the need for a structured approach Jean-François Hardy, Corresponding Author Jean-François Hardy From the Department of Anesthesiology, University of Montreal, Notre-Dame Hospital, Montréal, Québec, Canada.Jean-François Hardy, MD, FRCPC, Département d’anesthésiologie, Porte AS-1115-3, Pavillon Lachapelle, CHUM Hôpital Notre Dame, 1560 rue Sherbrooke est, Montréal, Québec H2L 4M1, Canada; e-mail: [email protected].Search for more papers by this author Jean-François Hardy, Corresponding Author Jean-François Hardy From the Department of Anesthesiology, University of Montreal, Notre-Dame Hospital, Montréal, Québec, Canada.Jean-François Hardy, MD, FRCPC, Département d’anesthésiologie, Porte AS-1115-3, Pavillon Lachapelle, CHUM Hôpital Notre Dame, 1560 rue Sherbrooke est, Montréal, Québec H2L 4M1, Canada; e-mail: [email protected].Search for more papers by this author First published: 09 May 2005 https://doi.org/10.1111/j.0041-1132.2005.00160.xCitations: 9Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume45, Issues1July 2005Pages 9S-13S RelatedInformation